Neuroscience News logo for mobile.
      Neuroscience News Logo

      Key Cause of Parkinson’s Can Be Treated

      FeaturedNeurologyOpen Neuroscience Articles
      ·December 1, 2016

      Summary: Researchers have identified a potential mechanism to help control inflammation associated with Parkinson’s disease.

      Source: University of New South Wales.

      A new Australian study modelling the early stages of Parkinson’s disease has given researchers insight into its causes and a possible treatment.

      A new Australian study that models the early stages of Parkinson’s disease has given researchers insight into its causes and a possible treatment.

      “We’ve shown how inflammation within the brain is related to the development of Parkinson’s disease, and we’ve identified a potential mechanism that can prevent this inflammation,” says lead author Dr Nic Dzamko, a NHMRC CJ Martin Fellowship holder in the Faculty of Medicine at UNSW in Sydney.

      “This is the result of four years’ worth of work, and we’re really excited by the outcomes. It offers hope and introduces a new target for therapeutic research, which we’re now working on,” says Dr Dzamko, who is based at Neuroscience Research Australia (NeuRA).

      Parkinson’s disease is the second most prevalent neurological condition after dementia. The disease is characterised by the abnormal accumulation in the brain of a protein called α-synuclein, as well as the loss of dopamine-producing cells in an area of the brain known as the substantia nigra.

      The loss of these cells causes the symptoms of Parkinson’s, including trembling, stiffness, slowness of movement and a loss of fine motor control.

      The NeuRA research team used pluripotent stem cell technology to turn human skin cells into neuronal cells in order to understand the effects of inflammation on the brain.

      “Although the exact causes of Parkinson’s disease are unknown, accumulating evidence suggests that inflammation plays a strong role in the development of the disease,” says Dr Dzamko.

      The brain uses toll-like receptors (TLR) to detect pathogens and regulate inflammation arising from compromised immunity. A consequence of activating TLR is the production of α-synuclein, which is responsible for creating ‘clumps’ of Lewy bodies; a hallmark of Parkinson’s disease.

      “We found that a particular toll-like receptor, TLR2, is increased in neurons in post-mortem PD brain tissue, which provided new information for us. Given that neurons accumulate α-synuclein in Parkinson’s disease, our results suggest that TLR2 is of central importance in understanding how the disease starts.”

      Image shows brain scans.
      Using stem cells, researchers activated TLR2, which created an inflammatory response that increased the levels of α-synuclein, suggesting that inflammation is a cause, at least in part, of Parkinson’s disease. NeuroscienceNews image is adapted from the University of New South Wales press release.

      Using stem cells, researchers activated TLR2, which created an inflammatory response that increased the levels of α-synuclein, suggesting that inflammation is a cause, at least in part, of Parkinson’s disease.

      “Given that we were able to find this association in the post-mortem brain tissue, then model this relationship in tissue culture, we’re confident that we’ve understood a key process in the development of Parkinson’s.”

      Crucially, the team also introduced a drug that inhibited TLR2, which prevented the increase of α-synuclein ‘clumping’ in the stem cell-derived neurons, suggesting it is a target for further research into therapeutic interventions.

      “The next stage will be to identify a drug that can be used in human trials, which acts on the pathway we’ve identified and prevents the TLR2-enabled increase in α-synuclein.”

      About this Parkinson’s disease research article

      Source: Chelsea Hunter – University of New South Wales
      Image Source: NeuroscienceNews.com image is credited to adapted from the University of New South Wales press release.
      Original Research: Full open access research for “Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology” by Nicolas Dzamko, Amanda Gysbers, Gayathri Perera, Anita Bahar, Amrita Shankar, Jianqun Gao, YuHong Fu, and Glenda M. Halliday in Acta Neuropathologica. Published online November 25 2016 doi:10.1007/s00401-016-1648-8

      Cite This NeuroscienceNews.com Article

      [cbtabs][cbtab title=”MLA”]University of New South Wales. “Key Cause of Parkinson’s Can Be Treated.” NeuroscienceNews. NeuroscienceNews, 1 December 2016.
      <https://neurosciencenews.com/parkinsons-tlr-neurology-5650/>.[/cbtab][cbtab title=”APA”]University of New South Wales. (2016, December 1). Key Cause of Parkinson’s Can Be Treated. NeuroscienceNews. Retrieved December 1, 2016 from https://neurosciencenews.com/parkinsons-tlr-neurology-5650/[/cbtab][cbtab title=”Chicago”]University of New South Wales. “Key Cause of Parkinson’s Can Be Treated.” https://neurosciencenews.com/parkinsons-tlr-neurology-5650/ (accessed December 1, 2016).[/cbtab][/cbtabs]


      Abstract

      Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology

      Inflammation is likely a key contributor to the pathogenesis of Parkinson’s disease (PD), a progressively debilitating neurodegenerative disease that is accompanied by a pathological accumulation of the α-synuclein protein in a staged manner through the brain. What leads to the accumulation of α-synuclein in PD and how this relates to inflammatory pathways, however, is not entirely clear. Toll-like receptor (TLR) signaling is a major pathway mediating inflammation and, in particular, TLR2 is increasingly being implicated in PD. We have, therefore, examined the expression of TLR2 in postmortem brain tissue from PD patients and matched controls. We confirm that TLR2 is increased in PD brain, and find that levels of TLR2 correlate with the accumulation of pathological α-synuclein. TLR2 was expressed on neurons as well as microglia; however, the neuronal rather than glial expression of TLR2 was significantly increased in PD brain in accordance with disease staging, and TLR2 was strongly localized to α-synuclein positive Lewy bodies. In cell culture, activation of neuronal TLR2 induced an inflammatory response, including the secretion of inflammatory cytokines and microglial-activating chemokines, as well as the production of reactive oxygen species. Moreover, activation of neuronal TLR2 increased levels of endogenous α-synuclein protein, which was in turn associated with increased levels of the autophagy/lysosomal pathway marker p62. Finally, promoting autophagy with rapamycin or pharmacological inhibition of the TLR2 signaling pathway prevented the TLR2-mediated increase in α-synuclein in neuronal cell cultures. These results implicate neuronal TLR2 expression in human PD pathogenesis. In particular, the increased expression of TLR2 on neurons may provide new insight into disease pathogenesis and/or options for therapeutic intervention.

      “Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology” by Nicolas Dzamko, Amanda Gysbers, Gayathri Perera, Anita Bahar, Amrita Shankar, Jianqun Gao, YuHong Fu, and Glenda M. Halliday in Acta Neuropathologica. Published online November 25 2016 doi:10.1007/s00401-016-1648-8

      Feel free to share this Neuroscience News.
      Join our Newsletter
      Thank you for subscribing.
      Something went wrong.
      I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
      Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
      We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
      Tags
      alpha-synucleinautophagyimmune systeminflammationneurodegenerative diseasesneuroinflammationNeurologyOpen Accessopen scienceParkinson's diseasesubstantia nigraTLRTLR2Toll like receptor 2University of New South Wales
      ShareTweetShareShareSubmitEmail
      Neuroscience News
      Neuroscience News posts science research news from labs, universities, hospitals and news departments around the world. Science articles cover neuroscience, psychology, AI, robotics, neurology, brain cancer, mental health, machine learning, autism, Parkinson's, Alzheimer's, brain research, depression and other sciences.
      Related
      This shows an older lady and a brain.

      Aging May Not Equal Chronic Inflammation

      This shows a neuron.

      Clearing Brain Sugar Stores Could Protect Against Dementia

      This shows an elderly couple.

      Cough Medicine Shows Promise in Slowing Parkinson’s Dementia

      Neuroscience News Footer Logo
      • Facebook
      • X
      • Instagram
      • YouTube
      • Linkedin

      Neuroscience News Sitemap
      Neuroscience Graduate and Undergraduate Programs
      Free Neuroscience MOOCs
      About
      Contact Us
      Privacy Policy
      Submit Neuroscience News
      Subscribe for Emails

      Neuroscience Research
      Psychology News
      Brain Cancer Research
      Alzheimer’s Disease
      Parkinson’s News
      Autism / ASD News
      Neurotechnology News
      Artificial Intelligence News
      Robotics News

      Search Neuroscience News

      Neuroscience News is an online science magazine offering free to read research articles about neuroscience, neurology, psychology, artificial intelligence, neurotechnology, robotics, deep learning, neurosurgery, mental health and more.

      Neuroscience News
      • Neuroscience
        • Featured
        • Neuroscience Videos
        • Neuro Web Stories
        • Open Access Neuroscience
        • Electrophysiology
        • Genetics
        • Neuroscience Programs
      • Neurology
        • Alzheimer’s Disease
        • Brain Research
        • Brain Cancer
        • Autism
        • Epilepsy
        • Traumatic Brain Injuries
        • Parkinson’s Disease
      • Psychology
        • Schizophrenia
        • Depression
        • Bipolar Disorder
        • Mental Health
      • AI
        • Neural Networks
        • Deep Learning
        • Machine Learning
      • Robotics
      • Neurotech
        • Brain Computer Interfaces
        • Neuroprosthetics
      • About
        • Neuroscience Newsletters
        • Submit Neuroscience News
        • Privacy Policy
        • Neuroscience News Sitemap
        • Contact Neuroscience News
        • Advertise on Neuroscience News
      Neuroscience News Small Logo
      • Neuroscience
        • Featured
        • Neuroscience Videos
        • Neuro Web Stories
        • Open Access Neuroscience
        • Electrophysiology
        • Genetics
        • Neuroscience Programs
      • Neurology
        • Alzheimer’s Disease
        • Brain Research
        • Brain Cancer
        • Autism
        • Epilepsy
        • Traumatic Brain Injuries
        • Parkinson’s Disease
      • Psychology
        • Schizophrenia
        • Depression
        • Bipolar Disorder
        • Mental Health
      • AI
        • Neural Networks
        • Deep Learning
        • Machine Learning
      • Robotics
      • Neurotech
        • Brain Computer Interfaces
        • Neuroprosthetics
      • About
        • Neuroscience Newsletters
        • Submit Neuroscience News
        • Privacy Policy
        • Neuroscience News Sitemap
        • Contact Neuroscience News
        • Advertise on Neuroscience News

      Categories

      • Artificial Intelligence
      • Auditory Neuroscience
      • Autism
      • Brain Cancer
      • Deep Learning
      • Electrophysiology
      • Events
      • Featured
      • Featured Articles
      • Genetics
      • Machine Learning
      • Most Popular
      • Neuroethics
      • Neurology
      • Neuroscience
      • Neuroscience Abstracts
      • Neuroscience Book Reviews
      • Neuroscience Business
      • Neuroscience Intros
      • Neuroscience News
      • Neuroscience News.com
      • Neuroscience Opinions
      • Neuroscience Videos
      • Neurotech
      • Open Neuroscience Articles
      • Pain
      • Psychology
      • Robotics
      • Sponsored Neuroscience News
      • Visual Neuroscience
      Neuroscience News LogoNeuroscience News
      This shows an ear.

      Gene Therapy Restores Hearing in Those with Deafness

      This shows a brain.

      Forever Chemicals May Disrupt Brain Development

      This shows kids playing games.

      Kids Outsmart AI in Puzzle Game That Builds Critical Thinking

      This shows a neuron.

      Drug-Coated Neural Implants Reduce Immune Rejection

      Start typing to see results or hit ESC to close
      Neuroscience neurobiology brain research Psychology Neurology
      See all results

      Subscribe

      Neuroscience News Daily Emails
      Go to Appearance > Customize > Subscribe Pop-up to set this up.